Remove Biomarkers Remove Innovation Remove Obesity
article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L. Innovations in Cardiorenal Metabolic Medicine The event will focus on the whole spectrum of cardiorenal metabolic disease, including obesity, diabetes, lipids, hypertension, and cardiorenal disease.

Education 100
article thumbnail

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations.

CME 64
article thumbnail

Top 10 Cardiac Diagnosis Trends in 2024

GEMMS

In this article, we will explore the top 10 trends shaping the future of cardiovascular medicine, highlighting the innovative technologies and approaches that are revolutionizing the field. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.

article thumbnail

Championing Change: Celebrating Cardiometabolic Health Congress (CMHC) Women Faculty

Cardiometabolic Health Congress

Her research focuses on women’s cardiovascular health and cardio-obstetrics, cardiovascular risk prediction using coronary artery calcium scores and biomarkers, lipids, and cardiometabolic diseases. She is one of the first fellowship-trained obesity medicine physicians in the world.

article thumbnail

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection. In the U.S.,

CME 103
article thumbnail

The legal case – naming a few names

Dr. Malcolm Kendrick

In the Sunday Times of April 23 rd , 2017, this article appeared, entitled ‘ Kellogg’s smothers health crisis in sugar – The cereals giant is funding studies that undermine official warnings on obesity.’ The study, published in the Journal Obesity Facts relied on evidence from 14 studies. Just to choose a few paragraphs. ‘